After two Big Pharma deals, Nimbus looks to keep the hits coming

After two Big Pharma deals, Nimbus looks to keep the hits coming

Submitted by admin on June 3, 2024 - 12:01pm
Source: 
Pharma Voice
News Tags: 
Nimbus Therapeutics
Gilead Sciences
MASH
Takeda
Headline: 
After two Big Pharma deals, Nimbus looks to keep the hits coming
snippet: 

Nimbus Therapeutics’ 2016 deal with Gilead Sciences, which is worth up to $1.2 billion for a MASH-related program, left some wondering if the win would be a fluke. 

Do Not Allow Advertisers to Use My Personal information